The “cicada” SARS-CoV-2 variant, which earned its nickname after staying relatively dormant following its discovery in 2024, has accounted for a small proportion of COVID-19 cases since the CDC began ...
A common side effect of many GLP-1 drugs is hair loss. It's creating a formerly untapped but growing market for hair ...
Pfizer PFE0.30%increase; green up pointing triangle reported lower fourth-quarter sales as demand for its Covid-19 vaccine and antiviral drug continued to decline. The drugmaker reported a loss of ...
An American born in 2024 can expect to live to age 79, on average, an increase of more than half a year from 2023, according to a report from the National Center for Health Statistics released ...
Hair loss isn’t something that you typically start to notice overnight. More often, it begins with the widening of your part line, or a patch of hair that’s looking a bit thinner than it used to be.
The incidence of fall-related fatalities in homes increased in older adults in the US following the onset of the COVID pandemic. Researchers conducted a retrospective analysis using data from the CDC ...
These top-rated hair growth treatments are loved by shoppers and can help with reducing shedding and supporting hair health, and they start at just $10. This concentrated serum supports hair health to ...
Hair loss and thinning can be frustrating, emotional, and, unfortunately, incredibly common. Whether you're spotting extra strands in the shower or noticing your ponytail feels thinner than it used to ...
Hair today, gone — and gray — tomorrow. More than 80 million people deal with hair loss, making prevention and growth a major industry. But while some causes are genetic and tough to head off, at ...
The fall COVID-19 vaccine season is starting slowly for Pfizer, with U.S. sales of its Comirnaty shots sinking 25% after federal regulators narrowed recommendations on who should get them. Approval of ...
The fall COVID-19 vaccine season is starting slowly for Pfizer, with U.S. sales of its Comirnaty shots sinking 25% after federal regulators narrowed recommendations on who should get them. Russian ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results